April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Inhibition of PRK-induced Corneal Haze By Trichostatin-A Involves Epigenetic Modification
Author Affiliations & Notes
  • Ashish Tandon
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Rangan Gupta
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Ajay Sharma
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Yasaman J. Hemmat
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Rajiv R. Mohan
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Footnotes
    Commercial Relationships  Ashish Tandon, None; Rangan Gupta, None; Ajay Sharma, None; Yasaman J. Hemmat, None; Rajiv R. Mohan, None
  • Footnotes
    Support  VA Merit 1I01BX000357-01 (RRM), NEI RO1EY17294 (RRM) and Unrestricted Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1988. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ashish Tandon, Rangan Gupta, Ajay Sharma, Yasaman J. Hemmat, Rajiv R. Mohan; Inhibition of PRK-induced Corneal Haze By Trichostatin-A Involves Epigenetic Modification. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1988.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recently we reported significant inhibition of photorefractive keratectomy (PRK)-induced haze in rabbit cornea by Trichostatin-A (TSA), a histone deacetylase inhibitor. This study investigated whether the anti-fibrotic effects of TSA on cornea are due to epigenetic modifications of TGFβ.

Methods: : Human corneal fibroblasts (HSF) and New Zealand White rabbits (2.5-3.0kg) were used. Fibrosis in HSF was induced with TGFβ (1ng/ml) using serum-free conditions and rabbit cornea with -9.0 diopter PRK with an excimer laser. Doses of TSA showing significant inhibition of corneal fibrosis were used for in vivo and in vitro experiments. Slit lamp biomicroscopy, biochemical assays (TUNEL, trypan blue, histone acetyltransferase, histone deacetylase), real-time PCR, western blotting, and immunocytochemistry techniques were used to examine epigenetic modifications.

Results: : TGFβ1 induced phenotypic changes, increased extracellular matrix synthesis and assembly of actin filaments (αSMA, fibronectin and phalloidin; 8-10±2.1 fold; p<0.01-0.001), and TSA significantly inhibited the levels of tested proteins and mRNA in HSF (46-83%; p<0.001) and rabbit corneal sections (73%; p<0.001). HSF treated with TGFβ1 reduced histone H3 acetylation whereas TSA treatment to TGFβ1-stimulated HSF showed dose-dependent restoration of acetylated histone H3 levels. Quantification studies are underway.

Conclusions: : This study suggests that epigenetic regulation plays an important role in corneal fibrosis. Understanding the molecular hierarchy of events with respect to reactivation of transcription and reversal of histone modification will be critical for understanding and developing mechanism-based anti-fibrotic treatments for corneal scarring.

Keywords: cornea: basic science • cornea: stroma and keratocytes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×